Scarica l'app Stockscreener
1.98
1.02%
0.02
Dopo l'orario di chiusura:
1.98
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CRBU Giù?
Forum
Previsione
Caribou Biosciences Inc Borsa (CRBU) Ultime notizie
Caribou Biosciences to Participate in Upcoming Investor Conferences - The Manila Times
Caribou Biosciences CEO to Present at Major Healthcare Conferences on CRISPR Advances | CRBU Stock News - StockTitan
The Rosen Law Firm, P.A. Announces Proposed Class Action - GlobeNewswire
The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Caribou Biosciences, Inc. – CRBU - GlobeNewswire Inc.
Steven Cohen's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com
Caribou Biosciences (NASDAQ:CRBU) Receives Buy Rating from HC Wainwright - MarketBeat
PFM Health Sciences, LP Increases Stake in Caribou Biosciences I - GuruFocus.com
Caribou Biosciences' SWOT analysis: biotech stock's potential amid clinical trials - Investing.com Australia
Caribou Biosciences, Inc. (CRBU) Reports Q3 Loss, Lags Revenue Estimates - MSN
Brokers Set Expectations for CRBU FY2024 Earnings - Defense World
Leerink Partnrs Issues Optimistic Forecast for CRBU Earnings - Defense World
What is Leerink Partnrs' Forecast for CRBU FY2024 Earnings? - MarketBeat
CRBU FY2024 EPS Increased by Brookline Capital Management - MarketBeat
Caribou Biosciences, Inc. (NASDAQ:CRBU) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance
Caribou Biosciences (NASDAQ:CRBU) Announces Quarterly Earnings Results - MarketBeat
Caribou Biosciences (NASDAQ:CRBU) vs. Sutro Biopharma (NASDAQ:STRO) Financial Analysis - Defense World
Caribou Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Caribou Biosciences earnings beat by $0.07, revenue fell short of estimates - Investing.com UK
Caribou Biosciences reports Q3 EPS (38c), consensus (45c) - TipRanks
Caribou Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update - StockTitan
CRISPR Technology Market Report 2024, with Profiles of Major Players Agilent Technologies, Beam Therapeutics, Caribou Biosciences, Crispr Therapeutics, Danaher, Genscript, Lonza and MoreResearchAndMarkets.com | FinancialContent Business Page - Financial Content
Caribou Biosciences, Inc.'s (NASDAQ:CRBU) Shares Bounce 25% But Its Business Still Trails The Industry - Simply Wall St
Vanguard Group Inc's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com
Critical Analysis: Caribou Biosciences (NASDAQ:CRBU) & Titan Pharmaceuticals (NASDAQ:TTNP) - Defense World
Is Caribou Biosciences (CRBU) a Promising Gene Editing Stock? - Insider Monkey
10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds - Insider Monkey
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Bought by Exchange Traded Concepts LLC - Defense World
STATE STREET CORP's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com
Following a 49% decline over last year, recent gains may please Caribou Biosciences, Inc. (NASDAQ:CRBU) institutional owners - Simply Wall St
Its Stock Has Paid Off Big Time For Caribou Biosciences Inc - SETE News
How to interpret Caribou Biosciences Inc (CRBU)’s stock chart patterns - US Post News
Daily Market Movement: Caribou Biosciences Inc (CRBU) Sees a 5.56 Increase, Closing at 1.90 - The Dwinnex
Dimensional Fund Advisors LP Has $4.30 Million Stock Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - MarketBeat
A better buy-in window may exist right now for Caribou Biosciences Inc (CRBU) - SETE News
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Purchased by Green Alpha Advisors LLC - Defense World
Caribou Biosciences Inc (CRBU) presents a great opportunity, but the stock is slightly undervalued - US Post News
Analyzing Ratios: Caribou Biosciences Inc (CRBU)’s Financial Story Unveiled - The Dwinnex
Susquehanna Fundamental Investments LLC Sells 91,637 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Acquired by American Century Companies Inc. - Defense World
Point72 DIFC Ltd Purchases 23,995 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Point72 Asset Management L.P. Decreases Stock Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - MarketBeat
Point72 Asset Management L.P. Sells 1,241,478 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
1,482,900 Shares in Caribou Biosciences, Inc. (NASDAQ:CRBU) Bought by Renaissance Technologies LLC - Defense World
31,831 Shares in Caribou Biosciences, Inc. (NASDAQ:CRBU) Purchased by Point72 Asia Singapore Pte. Ltd. - Defense World
Taking on analysts’ expectations and winning: Caribou Biosciences Inc (CRBU) - SETE News
Daily Market Movement: Caribou Biosciences Inc (CRBU) Sees a 2.06 Increase, Closing at 1.98 - The Dwinnex
Caribou Biosciences Inc (CRBU) presents a great opportunity, but the stock is slightly overvalued - US Post News
Caribou Biosciences: CB-010, chRDNA Technology Continue To Show Promise In Gene Editing - Seeking Alpha
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Acquired by Point72 DIFC Ltd - Defense World
Wall Street SWOT: Caribou Biosciences stockInnovative biotech with HLA-matching focus - Investing.com
CRISPR and CRISPR-Associated (Cas) Genes Market 2024 Business Standards and Competition Landscape 2032 – Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics – Cauverynews - Cauverynews
Stocks of Caribou Biosciences Inc (CRBU) are poised to climb above their peers - SETE News
CRBUCaribou Biosciences, Inc. Latest Stock News & Market Updates - StockTitan
0.93%
3.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):